Awareness, Present, and Future of Chronic Kidney Disease
LOS ANGELES, CA. January 13, 2022 /24-7PressRelease/ —
WHO: Kidneys Quest Foundation
WHAT: 2022 Kidney Disease Impact Conference
WHEN: Thursday, March 3, 2022, from 8:00 am to 1:15 pm (Pacific Time in the U.S.)
WHERE: The event will be streaming as a virtual healthcare conference, a full day series of informative webinars.
2022 THEME: The Impact of Awareness, Present, and Future of Chronic Kidney Disease
Topics will cover some of the challenges faced by present and future of chronic kidney disease. For example, individuals with diabetes and kidney disorders, updates on research, clinical trials, and advances in medicine.
We see a big opportunity for global collaboration between all stakeholders to strengthen primary healthcare, providing general community, patients, and caregivers a chance for improved quality of life. Questions continue to arise about living with kidney disease. How does one’s diet and lifestyle affect kidney disease? Does high blood pressure lead to kidney disease and, if not properly controlled, long-term dialysis? What new scientific discoveries are in the pipeline promising a more hopeful future for those with CKD?
WHAT TO EXPECT: This one-day event will feature leading experts, keynote speakers, panel discussions and workshops. Topics will cover some of the challenges faced by individuals with diabetes and kidney disorders. KQF is meeting this challenge by drawing together experts in several fields relating to renal disease and updating attendees on latest treatments, clinical trials, and medical advances. It allows both professionals, patients, and the general community to learn about these topics and spread the word more broadly–as CKD has rarely been given the attention it deserves.
SPEAKERS: Joseph C. Yu MD, FACC, Interventional Cardiology Medical Group / Zahi Nassoura MD FACS, San Fernando Valley Vascular/ Thomas Mone Chief Executive Officer OneLegacy
TOPICS INCLUDE: FAQs on / vascular disease as a cause by Diabetes & Heart disease / Cardiovascular Disease as a cause of Kidney Disease /Kidney disease as a cause of Cardiovascular disease / OneLegacy-UCLA kidney/stem cell tolerance trial.
For more information or to register for the 2022 Kidney Disease Impact Conference: https://events.zoom.us/ev/AM_-gvKC6_5W_CYRJckKskuMxo3xh6DwWr75z_0fDDw … 9j59pyHls4
Our Mission is to educate and provide people with knowledge about choices that are available, as well as options and alternatives for treatment and resources they might utilize. The goal of KQF is to guide, support and direct kidney patients when they feel they don’t know how to get to that next step. This includes how they can alleviate some of the fears and stress of living with a kidney disease. Helping patients navigate the healthcare, medical and social service systems throughout their journey.
For the original version of this press release, please visit 24-7PressRelease.com here